Vertex Pharmaceuticals Incorporated

Registered Principal Details

Business Or Interest:
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives.

Lobbying Interests:
Medicaid and Health Issues.

CEO Name:
Reshma Kewalramani

Contact
LB
Libby Brunsvold
50 Northern Avenue
Boston, MA 20001
(617) 961-7770
Libby_Brunsvold@vrtx.com
http://www.vrtx.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Tony Langenohl Exclusive Duties No Authorized On 12/30/2020 Withdrawn On N/A
William J McCoshen Exclusive Duties No Authorized On 12/30/2020 Withdrawn On N/A
Elizabeth Brunsvold Exclusive Duties No Authorized On 1/5/2021 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 744
Assembly Bill 744
Relating to: rare disease advisory council. (FE)

Bill Text and History

For
Notification Date
12/30/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Joint Resolution 82
Assembly Joint Resolution 82
Relating to: recognizing September as National Sickle Cell Awareness Month.

Bill Text and History

For
Notification Date
10/25/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 689
Senate Bill 689
Relating to: rare disease advisory council. (FE)

Bill Text and History

For
Notification Date
12/30/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Budget Bill Subjects

Agriculture, Trade, and Consumer Protection: Central Administrative Services
Biennial budget bill treatment of matter relating to
Agriculture, Trade, and Consumer Protection: Central Administrative Services

Notification Date
2/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Agriculture, Trade, and Consumer Protection: Food Safety and Consumer Protection
Biennial budget bill treatment of matter relating to
Agriculture, Trade, and Consumer Protection: Food Safety and Consumer Protection

Notification Date
2/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Health Services: Departmentwide
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide

Notification Date
2/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Health Services: Medicaid Services
Biennial budget bill treatment of matter relating to
Health Services: Medicaid Services

Notification Date
2/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Insurance: Departmentwide
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide

Notification Date
2/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Insurance: Supervision of the Insurance Industry
Biennial budget bill treatment of matter relating to
Insurance: Supervision of the Insurance Industry

Notification Date
2/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Public Service Commission: Departmentwide
Biennial budget bill treatment of matter relating to
Public Service Commission: Departmentwide

Notification Date
2/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Public Service Commission: Regulation of Public Utilities
Biennial budget bill treatment of matter relating to
Public Service Commission: Regulation of Public Utilities

Notification Date
2/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Revenue: Departmentwide
Biennial budget bill treatment of matter relating to
Revenue: Departmentwide

Notification Date
2/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Revenue: State and Local Finance
Biennial budget bill treatment of matter relating to
Revenue: State and Local Finance

Notification Date
2/24/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Development, drafting or introduction of a proposal related to sickle disease awareness month.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal related to sickle disease awareness month.

Action Intended To Affect
Both Legislative matter and rule

Notification Date
9/21/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Development, drafting or introduction of a proposal related to the treatment of sickle cell disease
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal related to the treatment of sickle cell disease

Action Intended To Affect
Both Legislative matter and rule

Notification Date
9/21/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Development, drafting or introduction of a proposal related to the creation of a rare disease advisory council.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal related to the creation of a rare disease advisory council.

Action Intended To Affect
Both Legislative matter and rule

Notification Date
9/21/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Development, drafting or introduction of a proposal Medicaid drug coverage process and procedure.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal Medicaid drug coverage process and procedure.

Action Intended To Affect
Both Legislative matter and rule

Notification Date
9/21/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Development, drafting or introduction of a proposal relating to regulation of pharmaceutical manufacturers.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to regulation of pharmaceutical manufacturers.

Action Intended To Affect
Both Legislative matter and rule

Notification Date
9/21/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Development, drafting or introduction of a proposal relating to treatment of cyclic fibrosis.
Development, drafting or introduction of a proposal relating to
Development, drafting or introduction of a proposal relating to treatment of cyclic fibrosis.

Action Intended To Affect
Both Legislative matter and rule

Notification Date
9/21/2021
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
Total Lobbying Expenditures 2021
January - June
$0.00
2021
July - December
$0.00
2022
January - June
$0.00
2022
July - December
$27,000.00
Total $27,000.00
Total Hours Communicating 2021
January - June
0.00
2021
July - December
0.50
2022
January - June
0.00
2022
July - December
1.00
Total 1.50
Total Hours Other 2021
January - June
9.00
2021
July - December
7.00
2022
January - June
7.50
2022
July - December
6.00
Total 29.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

No legislative bills/resolutions found.

Budget Bill Subjects

2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
50%
2021
July - December
2022
January - June
2022
July - December
25%
Total 23%
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
50%
2021
July - December
2022
January - June
2022
July - December
25%
Total 23%
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
2022
January - June
2022
July - December
25%
Total 6%

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

No topics found.

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2021
January - June
2021
July - December
2022
January - June
2022
July - December
Total
2021
January - June
2021
July - December
2022
January - June
2022
July - December
25%
Total 6%

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures